Gene · 5336
Papers3,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicle-packaged PD-L1 impedes macrophage-mediated antibacterial immunity in preexisting malignancy. | Cell Rep | 2024 | 39489940 | PubTator, text mining | PubMed |
| Alzheimer's disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner. | J Neuroinflammation | 2024 | 39487477 | PubTator, text mining | PubMed |
| Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies. | Cancers (Basel) | 2024 | 39456530 | PubTator, text mining | PubMed |
| A guide to selecting high-performing antibodies for PLC-gamma-2 for use in Western Blot, immunoprecipitation and immunofluorescence. | F1000Res | 2024 | 39429638 | PubTator, text mining | PubMed |
| Bioinformatics approaches for studying molecular sex differences in complex diseases. | Brief Bioinform | 2024 | 39397573 | PubTator, text mining | PubMed |
| Critical role of G protein-coupled receptor 40 in B cell response and the pathogenesis of rheumatoid arthritis in mice and patients. | Cell Rep | 2024 | 39392754 | PubTator, text mining | PubMed |
| EPO modified MSCs protects SH-SY5Y cells against ischemia/hypoxia-induced apoptosis via REST-dependent epigenetic remodeling. | Sci Rep | 2024 | 39370424 | PubTator, text mining | PubMed |
| NADPH oxidase 1/4 dual inhibitor setanaxib suppresses platelet activation and thrombus formation. | Life Sci | 2024 | 39293714 | PubTator, text mining | PubMed |
| Genetic regulation of B cell receptor signaling pathway: Insights from expression quantitative trait locus analysis using a mixed model. | Comput Biol Chem | 2024 | 39236423 | PubTator, text mining | PubMed |
| Eugenol: A Potential Modulator of Human Platelet Activation and Mouse Mesenteric Vascular Thrombosis via an Innovative cPLA2-NF-κB Signaling Axis. | Biomedicines | 2024 | 39200154 | PubTator, text mining | PubMed |
| PLCG2 variants in cherubism. | J Allergy Clin Immunol | 2024 | 39197752 | PubTator, text mining | PubMed |
| The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands. | Leukemia | 2024 | 39143370 | PubTator, text mining | PubMed |
| Unraveling the molecular pathogenesis of Type 2 Diabetes and its impact on female infertility: A bioinformatics and systems biology approach. | Comput Biol Med | 2024 | 39116715 | PubTator, text mining | PubMed |
| Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 39108206 | PubTator, text mining | PubMed |
| In vivo vitamin D target genes interconnect key signaling pathways of innate immunity. | PLoS One | 2024 | 39042613 | PubTator, text mining | PubMed |
| TNFRSF11A variants contribute to systemic autoinflammatory diseases: A case series of 12 patients. | Semin Arthritis Rheum | 2024 | 39003954 | PubTator, text mining | PubMed |
| PLCG2 Mutation in a Patient Presenting with Type 2 Autoimmune Hepatitis. | J Clin Transl Hepatol | 2024 | 38993509 | PubTator, text mining | PubMed |
| Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor. | Arthritis Rheumatol | 2024 | 38965708 | PubTator, text mining | PubMed |
| Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications. | Mod Pathol | 2024 | 38964503 | PubTator, text mining | PubMed |
| Human Inborn Errors of Immunity in Pyoderma Gangrenosum: A Systematic Review. | Am J Clin Dermatol | 2024 | 38951460 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5336/papers?page=10